Allarity Therapeutics (ALLR) S-4/A Registration of securities issued in business combination transactions (amended)

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-4 of Allarity Therapeutics, Inc., of our report dated August 20, 2021 relating to the financial statements of Allarity Therapeutics A/S, which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab

Copenhagen, Denmark

October 18, 2021